QAD's (QADA) "Neutral" Rating Reiterated at Sidoti

Wednesday, April 14, 2021 | MarketBeat

QAD (NASDAQ:QADA)'s stock had its "neutral" rating restated by investment analysts at Sidoti in a report issued on Wednesday, Benzinga reports. They currently have a $77.00 price objective on the software maker's stock. Sidoti's price target suggests a potential downside of 0.81% from the company's previous close.

QADA has been the topic of a number of other reports. Zacks Investment Research raised shares of QAD from a "sell" rating to a "hold" rating in a report on Thursday, February 18th. TheStreet raised shares of QAD from a "c+" rating to a "b" rating in a research note on Monday, April 5th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of "Buy" and a consensus target price of $56.50.

NASDAQ QADA opened at $77.63 on Wednesday. QAD has a 52 week low of $37.02 and a 52 week high of $78.95. The company has a market cap of $1.61 billion, a PE ratio of 485.22 and a beta of 1.32. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.10. The firm's 50-day simple moving average is $68.68 and its two-hundred day simple moving average is $59.54.

QAD (NASDAQ:QADA) last announced its quarterly earnings results on Tuesday, March 23rd. The software maker reported $0.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.21 by $0.38. QAD had a net margin of 1.08% and a return on equity of 3.21%. The firm had revenue of $82.98 million for the quarter, compared to the consensus estimate of $78.12 million. As a group, equities research analysts anticipate that QAD will post 0.09 EPS for the current year.

Hedge funds have recently made changes to their positions in the stock. Marshall Wace North America L.P. purchased a new stake in QAD in the first quarter worth $41,000. Arizona State Retirement System purchased a new position in QAD during the fourth quarter valued at $220,000. State Board of Administration of Florida Retirement System purchased a new position in QAD during the fourth quarter valued at $241,000. JPMorgan Chase & Co. lifted its position in QAD by 10.8% during the third quarter. JPMorgan Chase & Co. now owns 4,309 shares of the software maker's stock valued at $181,000 after buying an additional 421 shares during the period. Finally, Morgan Stanley lifted its position in QAD by 5.3% during the third quarter. Morgan Stanley now owns 7,642 shares of the software maker's stock valued at $323,000 after buying an additional 385 shares during the period. 47.03% of the stock is owned by institutional investors.

About QAD

QAD Inc provides cloud-based enterprise software solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers various software solutions, such as customer and service management solutions for manufacturers to acquire new customers; manufacturing solutions, which supports manufacturing business processes; enterprise asset management to manage, maintain, and install capital equipment; supply chain execution solutions that provides tools to support inventory and warehouse management; and financials solutions to manage and control finance and accounting processes.

See Also: Lock-Up Period Expiration

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: Can individual investors take part in an IPO?

7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the "7 Healthcare Stocks Delivering Innovation in 2021".

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.